Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Profit After Tax (2021 - 2026)

HeartSciences (HSCS) has disclosed Profit After Tax for 5 consecutive years, with -$2.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Profit After Tax fell 12.86% year-over-year to -$2.4 million, compared with a TTM value of -$9.0 million through Oct 2025, down 18.52%, and an annual FY2025 reading of -$8.8 million, down 32.7% over the prior year.
  • Profit After Tax was -$2.4 million for Q4 2025 at HeartSciences, down from -$2.1 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$501851.0 in Q3 2021 and bottomed at -$2.5 million in Q1 2025.
  • Average Profit After Tax over 5 years is -$1.7 million, with a median of -$1.8 million recorded in 2022.
  • The sharpest move saw Profit After Tax tumbled 213.5% in 2022, then rose 20.49% in 2023.
  • Year by year, Profit After Tax stood at -$1.0 million in 2021, then crashed by 74.58% to -$1.8 million in 2022, then increased by 3.22% to -$1.7 million in 2023, then dropped by 19.13% to -$2.1 million in 2024, then dropped by 12.86% to -$2.4 million in 2025.
  • Business Quant data shows Profit After Tax for HSCS at -$2.4 million in Q4 2025, -$2.1 million in Q3 2025, and -$2.1 million in Q2 2025.